Locin-M Tablet is a combination medication containing Levocetirizine 5mg and Montelukast 10mg, indicated for the management of allergic conditions such as allergic rhinitis and chronic urticaria. Levocetirizine, a third-generation non-sedative antihistamine, selectively inhibits peripheral H1 receptors, thereby reducing symptoms like sneezing, nasal congestion, itching, and rhinorrhea. Montelukast, a leukotriene receptor antagonist, blocks cysteinyl leukotriene receptors, which play a key role in the inflammatory process associated with asthma and allergic rhinitis. The synergistic action of these two agents provides comprehensive relief from allergic symptoms by targeting different pathways of the allergic response. Locin-M is particularly beneficial in patients who require both antihistaminic and anti-inflammatory effects for optimal symptom control. It is administered orally, typically once daily in the evening, to enhance compliance and effectiveness. Common side effects may include headache, fatigue, and gastrointestinal disturbances, though it is generally well tolerated. Caution is advised in patients with hepatic impairment and those with a history of neuropsychiatric events. Locin-M should be used under medical supervision, with dosage adjustments as necessary based on clinical response and patient tolerance.

Dosage & How to Use